1.
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
by Arbyn, M
Clinical microbiology and infection, 2015-09, Vol.21 (9), p.817-826
2.
MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells
by Wan, Hai-Ying
Cancer letters, 2014, Vol.355 (1), p.148-158
3.
Human Papillomavirus, Human Immunodeficiency Virus and Immunosuppression
by Denny, Lynette A
Vaccine, 2012, Vol.30, p.F168-F174
4.
HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA
by Vidal, Adriana C
Cancer causes & control, 2014-08-01, Vol.25 (8), p.1055-1062
5.
The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 C...
by Zhao, X
Clinical microbiology and infection, 2018-12, Vol.24 (12), p.1322-1327
6.
Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States
by Chesson, Harrell W
Vaccine, 2012, Vol.30 (42), p.6016-6019
7.
B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells
by Sun, Yanrui
Cancer letters, 2016, Vol.375 (2), p.284-292
8.
The infiltration and functional regulation of eosinophils induced by TSLP promote the proliferation of cervical cancer cell
by Xie, Feng
Cancer letters, 2015, Vol.364 (2), p.106-117
9.
The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana
by Vodicka, Elisabeth
Vaccine, 2022-03-31, Vol.40, p.A85-A93
10.
11.
Can We Define the Risk of Lymph Node Metastasis in Early-Stage Cervical Cancer Patients? A Large-Scale, Retrospective Study
by Ferrandina, Gabriella
Annals of surgical oncology, 2017-06-12, Vol.24 (8), p.2311-2318
12.
13.
Management of recurrent cervical cancer: A review of the literature
by Peiretti, M
Surgical oncology, 2011, Vol.21 (2), p.e59-e66
14.
High-risk HPV prevalence among women undergoing cervical cancer screening: Findings a decade after HPV vaccine implementation in British Columbia, Canada
by Litwin, Charles
Vaccine, 2021-08-23, Vol.39 (36), p.5198-5204
15.
Overview of Cervical Cancer Screening Practices in the Extended Middle East and North Africa Countries
by Sancho-Garnier, Hélène
Vaccine, 2012, Vol.31, p.G51-G57
16.
Polymerase Chain Reaction Human Papillomavirus (HPV) Detection and HPV Genotyping in Invasive Cervical Cancers With Prior Negative HC2 Test Results
by Tao, Xiang
American journal of clinical pathology, 2017-05-01, Vol.147 (5), p.477-483
17.
Implementation of Human Papillomavirus Immunization in the Developing World
by Kane, Mark A
Vaccine, 2012, Vol.30, p.F192-F200
18.
Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries
by Canfell, Karen
Vaccine, 2012, Vol.30 (suppl 5), p.F157-F167
19.
Completion Surgery After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Comprehensive Analysis of Pattern of Postoperative Complications
by Ferrandina, Gabriella
Annals of surgical oncology, 2014-01-10, Vol.21 (5), p.1692-1699
20.
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospect...
by Rufini, Vittoria
European journal of nuclear medicine and molecular imaging, 2019-08-14, Vol.47 (5), p.1228-1238
